Market revenue in 2023 | USD 299.4 million |
Market revenue in 2030 | USD 572.9 million |
Growth rate | 9.7% (CAGR from 2023 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Services |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Kits & Reagents, Services |
Key market players worldwide | Agilent Technologies Inc, Roche Holding AG ADR, Illumina Inc, Qiagen NV, Thermo Fisher Scientific Inc, Eurofins Scientific SE, Merck KGaA, Bio-Rad Laboratories Inc, Pacific Biosciences of California Inc, Danaher Corp, Promega, Affymetrix |
Key Regions: U.S. , UK , Japan , Brazil , South Africa
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to rna analysis market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 57.98% in 2023. Horizon Databook has segmented the Middle East & Africa rna analysis market based on instruments, kits & reagents, services covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa rna analysis market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa rna analysis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account